Artesunate has a possibility to interact with more drugs. These interactions are harmful. Drug interactions can be prevented by avoiding unwanted drug combinations.

Ugandan trial shows reduced efficacy of artemether-lumefantrine for malaria, with resistance mutations causing higher ...

Artesunate for Injection is now available for the initial treatment of severe malaria in adult and pediatric patients. Artesunate and its metabolite dihydroartemisinin (DHA) are both active ...

Women treated with mefloquine–artesunate and those treated with amodiaquine–artesunate had a significantly higher incidence of any adverse event (84.9% [722 of 850 women] and 79.0% [665 of 842 ...

Dr Yeşim Tozan et al. Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis. The Lancet, 30 November 2010 DOI: 10.1016/S0140-6736 (10)61460-2 ...

Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial. PLOS Medicine, 2016; 13 (1): e1001938 DOI: 10.1371/journal.pmed.1001938 ...

Artesunate is recommended by the World Health Organization (WHO) but has not been approved by the US Food and Drug Administration (FDA). "While at this time, artesunate is neither FDA-approved nor ...

Because artesunate had not yet been approved by the Food and Drug Administration, patients needing treatment for severe malaria were required to sign lengthy and confusing consent forms for ...

A slowdown in the clearance of parasites in patients treated with artesunate sounded alarms when it was first reported from Cambodia. Subsequently, similar delays in parasite clearance were noted ...

Artesunate AMIVAS, approved by EU Commission and U.K.’s Medicine and Healthcare Product Regulatory Agency to treat severe malaria both in children and adults in Europe, is the only fully ...

Artesunate for Injection is now available for the initial treatment of severe malaria in adult and pediatric patients. Artesunate and its metabolite dihydroartemisinin (DHA) are both active ...